Purchase Order 80NSSC24PC154

Award Date 8/28/24
Potential Completion Date 3/28/25
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
MOFFETT FIELD, CA 94035, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $18,728 firm fixed price purchase order to Vectorbuilder Inc. for the generation of an OCVAR8 stable cell line plasmid synthesis services. This contract does not have a set-aside designation, indicating that Vectorbuilder competed for the award in full and open competition. Vectorbuilder is a specialized biotechnology company that provides molecular...
Vectorbuilder Inc. has been awarded a firm fixed price purchase order in the amount of $11,437 by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases to provide custom adeno-associated virus packaging. No set-aside designation was applied to this procurement. Per the award description, Vectorbuilder will deliver molecular cloning services to support the NIDDK's biomedical research efforts. As a global leader in gene delivery technologies,...
The National Institute of Neurological Disorders and Stroke, a component of the National Institutes of Health, awarded a $15,238 firm fixed price purchase order to Vectorbuilder Inc. for AAV8 large-scale 10 and ultra-purification packaging services. The contract has an ultimate completion date of August 26, 2025. Vectorbuilder is a specialized biotechnology company that provides gene delivery and molecular biology services to various federal agencies, including the Department of Veterans Affairs...
This firm fixed-price contract for $803,500.00 was awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to Vector Biomed Inc. for the production and stability testing of clinical grade lentiviral vector. The services include manufacturing a minimum of 50mg of GMP/clinical grade transfer plasmid and 400ml of concentrated, GMP grade lentiviral vector, as well as performing stability testing...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services, awarded a $16,999 firm fixed-price purchase order to Vectorbuilder Inc., a specialized biotechnology company, for large-scale 15 and ultra-purification packaging service for PAAV240227-1016XNQ. The contract, which does not utilize any set-aside designations, has a completion date of September 3, 2025. Vectorbuilder, a global leader in gene delivery...
This federal contract award, valued at $10,600.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The contract was awarded to Vector Biosystems, Inc., doing business as Vector Biolabs, a minority-owned, small disadvantaged biotechnology company that provides gene delivery products and services. The contract is for the delivery of an AAV8-SPC512-MCHERRY construct, which is likely a gene...
This purchase order awards Vector Biosystems, Inc., doing business as Vector Biolabs, $12,060 to deliver two custom adeno-associated viral constructs to the National Center for Advancing Translational Sciences within the Department of Health and Human Services' National Institutes of Health. Specifically, Vector Biosystems will provide one AAV6 vector containing GFP and an shRNA targeting human COLQ, and one AAV6 vector containing GFP and an shRNA targeting human DOK7. Both constructs are to...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a purchase order contract valued at one hundred twenty thousand six hundred dollars ($120,600) to Vector Biomed Inc. The contract is to obtain preclinical grade lentiviral vectors in support of NCI's Pediatric Oncology Branch investigational new drug enabling studies and demonstration of clinical-grade vector production feasibility. Services include receipt confirmation...
This firm fixed-price purchase order contract was awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Vector Biosystems, Inc. (doing business as Vector Biolabs), a minority-owned and small disadvantaged for-profit biotechnology company. The $10,870.00 contract is for the delivery of adeno-associated viruses (AAVs) to express mitochondrial and cytosolic-targeted reactive oxygen species (ROS) sensitive proteins. This will support...
Vector Biosystems, Inc., doing business as Vector Biolabs, has been awarded a firm fixed-price purchase order valued at three thousand six hundred twenty-five U.S. dollars ($3,625) by the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism (NIAAA). The contract term is from November 24, 2017 through November 23, 2018 for Vector Biolabs to provide unspecified products or services to NIAAA in support of its biomedical research programs. Place of performance will be...

The U.S. government awarded a $23,434 firm fixed price purchase order contract to Vectorbuilder Inc., a small business biotechnology company, to provide stable cell line generation contract research organization (CRO) services. The contract was awarded by the Shared Services Center, a civilian agency, and has a completion date of March 28, 2025. Vectorbuilder has a proven track record of supporting biomedical research efforts across multiple NIH institutes and the Department of Veterans Affairs with its expertise in gene delivery technologies, molecular cloning, and DNA preparation services. This contract award demonstrates the company's continued reliability as a partner for government agencies seeking advanced molecular biology solutions.

Generated 8/29/24, 9:43 AM